GeneNews Finds China Distribution Partner for Cancer Test

GeneNews Limited, a Toronto-based company focused on molecular diagnostic tests, signed up GeneDiagnostics Inc. as its non-exclusive China marketing partner for ColonSentry™, a blood-based test that determines a person's current risk for colorectal cancer. ColonSentry, the company’s first marketed product, is available in parts of Canada. More details...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.